Assignee
INSTITUTO NAC DE INVESTIGACIONES NUCLEARES
MX·3 granted patents·1 pending application·1 citations·filing 2017–2024
Top patents by PatentIndex Score
4 records- 0164US12128114B2177Lu-DOTA-HYNIC-iPSMA as a therapeutic radiopharmaceutical targeting prostate-specific membrane antigenINSTITUTO NAC DE INVESTIGACIONES NUCLEARES·Filed 2019·Granted Oct 29, 2024·1 cites·10 claims
- 0258US11547767B299mTc-EDDA/HYNIC-iPSMA as a radiopharmaceutical for detecting the overexpression of prostate-specific membrane antigenINSTITUTO NAC DE INVESTIGACIONES NUCLEARES·Filed 2020·Granted Jan 10, 2023·0 cites·7 claims
- 0354US10918745B299mTc-EDDA/HYNIC-iPSMA as a radiopharmaceutical for detecting the overexpression of prostate specific membrane antigenINSTITUTO NAC DE INVESTIGACIONES NUCLEARES·Filed 2017·Granted Feb 16, 2021·0 cites·1 claims
- 0446US2025009911A1DOTA-HYNIC-iPSMA AS A THERAPEUTIC RADIOPHARMACEUTICAL TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGENINSTITUTO NAC DE INVESTIGACIONES NUCLEARES·Filed 2024·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when INSTITUTO NAC DE INVESTIGACIONES NUCLEARES files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →